Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 3 , Pages 171-175 , September 2008

Topical photodynamic therapy in the treatment of hidradenitis suppurativa

  • R.F. Rose, MRCP

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 113 2432799; fax: +44 113 3923564.
    • ,
  • G.I. Stables, FRCP MD

References 

  1. Moschella SL. Hidradenitis suppurativa: complications resulting in death. JAMA. 1966;198:83–85
  2. Harrison BJ, Mudge M, Hudges LE. Recurrence after surgical treatment of hidradenitis suppurativa. BMJ. 1987;294:487–489
  3. Mortimer PS, Dawber RPR, Gales MA, Moore RA. Mediation of hidradenitis suppurativa by androgens. BMJ. 1986;292:245–248
  4. Fitzsimmons JS, Guilbert PR, Fitzsimmons EM. Evidence of genetic factors in hidradenitis suppurativa. Br J Dermatol. 1985;113:1–8
  5. Yu CC, Cook MG. Hidradenitis suppurativa: disease of follicular epithelium rather than disease of apocrine glands. Br J Dermatol. 1990;122:763–769
  6. Clemmenson OJ. Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol. 1983;22:325–328
  7. Mortimer PS, Dawber RP, Gales MA, Moore RA. A double blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol. 1986;115:263–268
  8. Chow ETY, Mortimer PS. Successful treatment of hidradenitis suppurativa and retroauricular acne with etretinate. Br J Dermatol. 1992;126:415
  9. Buckley DA, Rogers S. Cyclosporin-responsive hidradenitis suppurativa. J R Soc Med. 1995;88:289–290
  10. Fardet L, Dupuy A, Kerob D, et al. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients. J Am Acad Dermatol. 2007;56(4):624–628
  11. Giamarellos-Bourboulis EJ, Pelekanou E, Antonopoulou A, et al. An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa. Br J Dermatol. 2008;158(3):567–572
  12. Banerjee AK. Surgical treatment of hidradenitis suppurativa. Br J Surg. 1992;79:863–866
  13. Szeimies RM, Calzavara-Pinton P, Karrer S, Ortel B, Landthaler M. Topical photodynamic therapy in dermatology. J Photochem Photobiol B. 1996;36(2):213–219
  14. Divaris DX, Kennedy JC, Pottier RH. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolaevulinc acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol. 1990;136:891–897
  15. Mitra A, Stables GI. Topical photodynamic therapy for non-cancerous skin conditions. Photodiagn Photodynam Therapy. 2006;3:116–127
  16. Gold MH, Bridges TM, Bradshaw VL, Boring M. ALA-PDT and blue light therapy for hidradenitis suppurativa. J Drugs Dermatol. 2004;3:S32–S39
  17. Strauss RM, Pollock B, Stables GI, Goulden V, Cunliffe WJ. Photodynamic therapy using aminolaevulinc acid does not lead to clinical improvement in hidradenitis suppurativa. Br J Dermatol. 2005;152:803–804
  18. Rivard J, Ozog D. Henry Ford Hospital Dermatology experience with Levulan Kerastick and blue light photodynamic therapy. J Drugs Dermatol. 2006;5(6):556–561
  19. Sartorius K, Lapins J, Emtestam L, Jemec GBE. Suggestion for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol. 2003;149:211–213
  20. Gold MH. Aminolevulinc acid photodynamic therapy for hidradenitis suppurativa. Dermatol Clin. 2007;25:67–73
  21. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RR. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol. 2000;115:183–192
  22. Jemec GBE, Gniadecka M. Sebum excretion in hidradenitis suppurativa. Dermatology. 1997;194:325–328

PII: S1572-1000(08)00074-4

doi: 10.1016/j.pdpdt.2008.07.002

Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 3 , Pages 171-175 , September 2008

Article Tools

* Image Usage & Resolution